Using Informatics to Advance Use, Safety, and Effectiveness of COVID-19 Medical Products

Description

The COVID-19 pandemic is a health crisis of unprecedented scale. While there are many facets to an effective response, clinical informatics can assist regulators, policy makers, and other stakeholders in optimizing medical product use and value. Drawing on the experience of nationally renowned clinicians, scientists, and regulatory experts, and sponsored by the U.S. Food and Drug Administration and the Johns Hopkins Center of Excellence in Regulatory Science and Innovation (JH-CERSI), this two-part webinar will provide a stimulating and timely analysis of the use of clinical informatics in optimizing the regulatory and public health response to the COVID-19 pandemic in the U.S. Learn more about the webinar series.

Webinar #2: Using Informatics to Advance Use, Safety, and Effectiveness of COVID-19 Medical Products

This 90-minute webinar will focus on the applied use of informatics to examine COVID-19 medical product evaluation. Particular emphasis will be given to knowledge dissemination about therapeutics, devices, and diagnostics covered under emergency-use authorizations and approaches to rapidly generate new insights regarding SARS-CoV-2 infection, including among racial and ethnic minorities, pregnant women, children, and the elderly.

Speakers:

• Rear Adm. Richardae Araojo, Food and Drug Administration
• Jessica Mega, Verily
• Donna Rivera, Food and Drug Administration
• Brian Garibaldi, Johns Hopkins University
• Jodi Segal, Johns Hopkins University